Gregory VandenBosch

Greg centers his business interests on the consumerist movement in healthcare. Prior to HealthBridge, Greg was an early investor and Executive VP Corporate Strategy at RespondWell, a telemedicine startup sold to Zimmer Biomet in 2016 (NYSE and SIX: ZBH). Greg is also the founder of MedDirect, Inc., a healthcare revenue cycle management company acquired by MedNax, Inc. (NYSE: MD). He is graduate of Hope College in Holland, MI. Greg is always on the hunt for the perfect fly-fishing location and never misses his daily run.